ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
theoc
|
216 |
95K |
24 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
216
|
95K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene & Kincell Bio Strategic Partnership Investor Webinar
|
|
theoc
|
51 |
19K |
47 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
51
|
19K
|
47
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
theoc
|
32K |
15M |
3 |
12/04/24 |
12/04/24 |
Charts
|
32K
|
15M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
IMU - up 90% in the past 6 months of trade.
|
|
theoc
|
25 |
7.0K |
25 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
25
|
7.0K
|
25
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
theoc
|
23K |
11M |
54 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
23K
|
11M
|
54
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
theoc
|
303 |
121K |
22 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
121K
|
22
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
|
|
theoc
|
303 |
121K |
35 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
303
|
121K
|
35
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
theoc
|
2.6K |
1.0M |
13 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
2.6K
|
1.0M
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
theoc
|
126 |
31K |
7 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
31K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
theoc
|
13K |
6.3M |
30 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
13K
|
6.3M
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
theoc
|
126 |
31K |
14 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
31K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
theoc
|
13K |
6.3M |
13 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
13K
|
6.3M
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
theoc
|
742 |
328K |
11 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
742
|
328K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
theoc
|
126 |
31K |
5 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
theoc
|
126 |
31K |
11 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
theoc
|
126 |
31K |
7 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
theoc
|
196 |
36K |
13 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
196
|
36K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
theoc
|
317 |
79K |
5 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
317
|
79K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
theoc
|
196 |
36K |
4 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
196
|
36K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
theoc
|
196 |
36K |
4 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
196
|
36K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
theoc
|
317 |
79K |
13 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
317
|
79K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
theoc
|
317 |
79K |
10 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
317
|
79K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
theoc
|
100 |
26K |
26 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
100
|
26K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
theoc
|
282 |
74K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
282
|
74K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Big Pharma buyouts.
|
|
theoc
|
39 |
9.3K |
12 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
9.3K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
theoc
|
58 |
15K |
10 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
58
|
15K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
theoc
|
317 |
79K |
7 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
317
|
79K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
theoc
|
2.6K |
1.0M |
8 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
2.6K
|
1.0M
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
theoc
|
58 |
15K |
27 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
58
|
15K
|
27
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
theoc
|
56 |
29K |
20 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
56
|
29K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
theoc
|
317 |
79K |
2 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
317
|
79K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
theoc
|
317 |
79K |
5 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
317
|
79K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
theoc
|
1.3K |
324K |
11 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
1.3K
|
324K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
theoc
|
742 |
328K |
6 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
742
|
328K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
theoc
|
317 |
79K |
12 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
317
|
79K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
theoc
|
317 |
79K |
16 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
317
|
79K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
theoc
|
317 |
79K |
8 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
317
|
79K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
theoc
|
317 |
79K |
13 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
317
|
79K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA holders as at 29 Feb 2024
|
|
theoc
|
11 |
3.4K |
6 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
11
|
3.4K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
theoc
|
1.3K |
324K |
8 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
1.3K
|
324K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
theoc
|
317 |
79K |
21 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
317
|
79K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
theoc
|
1.3K |
324K |
6 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.3K
|
324K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
theoc
|
1.3K |
324K |
9 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.3K
|
324K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
theoc
|
1.3K |
324K |
5 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.3K
|
324K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
theoc
|
152 |
45K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
45K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
theoc
|
1.3K |
324K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.3K
|
324K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
theoc
|
209 |
49K |
4 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
49K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
theoc
|
114 |
33K |
11 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
114
|
33K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
theoc
|
114 |
33K |
9 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
33K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
theoc
|
114 |
33K |
10 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
33K
|
10
|
|